Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 22 years or older
- People who have been diagnosed with glioblastoma (GBM), confirmed through laboratory testing of tumour tissue
- People who have already had surgery to remove as much of the tumour as safely possible, followed by a full course of radiation therapy (either a 6-week course or a shorter 3-week course)
- People with any variation of certain tumour genetic markers (related to MGMT and IDH gene characteristics)
- People whose blood, liver, and kidney function are at adequate levels (confirm with trial site)
- People who are willing to use a device called Tumour Treating Fields (TTFields), which delivers low-intensity electrical fields to the tumour area
Who may not be able to join:
- People whose GBM is located in the lower part of the brain, below a structure called the tentorium (confirm with trial site)
- People who are pregnant
- People with serious existing health conditions that would prevent them from safely receiving standard chemotherapy (called temozolomide)
- People who have an active implanted medical device (such as a pacemaker, defibrillator, deep brain stimulator, spinal cord stimulator, vagus nerve stimulator, or programmable shunt), a skull defect where bone is missing without replacement, or bullet fragments in the body
- People who have a known sensitivity or allergic reaction to conductive gels, such as those used on ECG stickers or TENS electrode pads
- People who have significant bleeding in or around the area where the tumour was located, which could affect the quality of brain scans
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Suyash Mohan, MD, PDCC, University of Pennsylvania
Phone: 267-408-0977
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to Progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.